-
-
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
2023-01-17
-
-
Fosun Receives RMB12 Billion Syndicated Loan from 8 Banks to Jointly Promote Development of the Private Economy
2023-01-16
On 16 January 2023, Shanghai Fosun High Technology (Group) Co., Ltd. (“Fosun High Technology”) and eight domestic banks held a syndicated loan signing ceremony at the Bund Finance Center, Shanghai. According to the agreement, Industrial and Commercial Bank of China, Agricultural Bank of China, Bank of China, China Construction Bank, an
-
-
Fosun International Receives Four Awards from Corporate Governance Asia
2023-01-11
Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International win Asia’s Best CEO from Corporate Governance AsiaFosun International also receives Asia’s Best CSR and Best Corporate Communications AwardsOn 11 January 2023, the Corporate Governance Asia magazine presented the 12th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Execu
-
-
Fosun Foundation Partners with Fosun Pharma, and Genuine Biotech to Donate RMB100 Million Worth of Azvudine to 180 Counties in the Central and Western Rural Areas of China
2023-01-09
On 9 January 2023, Fosun Foundation, togetherwith Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) and HenanGenuine Biotech Co., Ltd. (“Genuine Biotech”) announced a donation of RMB100 million worth of oral medication forCOVID-19 Azvudine to 180counties in the central and western rural areas of China in phases. WeProtect Rural Doctors, Rural D
-
-
Self-Paid Vaccination Service for Bivalent COVID-19 Vaccine COMIRNATY® is Officially Provided in Hong Kong, Offering More Vaccine Options for People in Need
2023-01-06
(HONG KONG, CHINA, January 6, 2023) - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) announced that the Group has provided bivalent COVID-19 Vaccine COMIRNATY® (“Comirnaty bivalent vaccine”) to the private medical system in Hong Kong Special Administrative Region of the People’s Republic of China
-
-
Fosun Tourism’s Businesses in China Deliver Outstanding Performance during New Year Holiday Seizes Momentum from Reopening and Leads Industry Recovery
2023-01-05
(Hong Kong, 5 January 2023) – Fosun Tourism Group (“Fosun Tourism” or the “Group”, Hong Kong Stock Exchange Stock Code: 1992), a world-leading leisure-focused integrated tourism group, announced that during the 2023 New Year holiday period, the Group's core businesses in China, including Atlantis Sanya and Lijiang Foliday Town surpassed their
-
-
Guo Guangchang’s New Year’s Message: 2023 After the Rain Comes the Rainbow
2022-12-31
Dear Fosuners,In just a few hours, the year 2022 will come to an end. I just visited the Yuyuan Garden to have a look at this year’s Lantern Festival. The team told me in advance that this year’s Lantern Festival has been upgraded in all aspects, but it still felt very surreal when I was on the Nine-turn Bridge.The history of the Yuyuan Garden Lantern Festival can be traced back
-
-
Fosun 2022 Recap: 10 Moments of the Year
2022-12-30
The year has come to an end.Ten moments documented Fosun’s keywords of the year and witnessed the passing of our 2022.COMIRNATY® COVID-19 mRNA Vaccine. The self-paid vaccination service of the COMIRNATY® bivalent vaccine, which can protect against the Omicron variant, was rolled out in Hong Kong SAR and Macao SAR. Vaccination became available to German citizens living in the Chinese
-
-
Fosun International Garners Multiple ESG Awards in Domestic and International Markets
2022-12-30
(30 December 2022) Recently, Fosun International received numerous accolades in domestic and international markets, including multiple ESG awards from international financial media International Business Magazine, Finance Derivative and Hong Kong stock connect information platform Zhitong Caijing.